Cargando…
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
Renal medullary carcinoma (RMC) is a rare and deadly kidney cancer in patients of African descent with sickle cell trait. We have developed faithful patient-derived RMC models and using whole-genome sequencing, we identified loss-of-function intronic fusion events in one SMARCB1 allele with concurre...
Ejemplares similares
-
RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
por: Khadka, Prasidda, et al.
Publicado: (2020) -
OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma
por: Rendo, Veronica, et al.
Publicado: (2021) -
HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS
por: Boynton, Adam, et al.
Publicado: (2020) -
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters
por: Nakayama, Robert T., et al.
Publicado: (2017) -
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
por: Misek, Sean, et al.
Publicado: (2022)